Mutation-specific therapies and drug repositioning in cystic fibrosis.

Villella, Valeria R; Tosco, Antonella; Esposito, Speranza; Bona, Gianni; Raia, Valeria; Maiuri, Luigi

Villella, Valeria R; Tosco, Antonella; Esposito, Speranza; Bona, Gianni; Raia, Valeria; Maiuri, Luigi.

Afiliación

Villella VR; European Institute for Research in Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy.
Tosco A; Unit of Pediatrics, Regional Cystic Fibrosis Center, Department of Translational Medical Sciences, Federico II University, Naples, Italy.
Esposito S; European Institute for Research in Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy.
Bona G; Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Raia V; Unit of Pediatrics, Regional Cystic Fibrosis Center, Department of Translational Medical Sciences, Federico II University, Naples, Italy.
Maiuri L; European Institute for Research in Cystic Fibrosis, San Raffaele Scientific Institute, Milan, Italy - luigi.maiuri@gmail.com.

Minerva Pediatr ; 71(3): 287-296, 2019 Jun.

Article en En | MEDLINE | ID: mdl-30761820

Asunto(s)

Regulador de Conductancia de Transmembrana de Fibrosis Quística/genética; Fibrosis Quística/tratamiento farmacológico; Diseño de Fármacos; Animales; Fibrosis Quística/genética; Reposicionamiento de Medicamentos; Quimioterapia Combinada; Humanos; Terapia Molecular Dirigida; Mutación

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diseño de Fármacos / Regulador de Conductancia de Transmembrana de Fibrosis Quística / Fibrosis Quística Límite: Animals / Humans Idioma: En Revista: Minerva Pediatr Año: 2019 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google